Healthcare is one example, out of favor for 12+ months due to government being a big customer and worries about a squeeze. But not all healthcare is equal. Example: Becton Dickinson has ~60% market share in catheters and syringes, essential products. As medications shift to biologicals (complex, often self-administered, high price points), Becton Dickinson has room for growth over 10-20 years, trades at ~12x earnings, and buys back its own stock.